A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM
India
TyphiBEVTM
Typhoid
adults
children
conjugate vaccine
infants
intramuscular
Journal
Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652
Informations de publication
Date de publication:
30 11 2022
30 11 2022
Historique:
pubmed:
26
3
2022
medline:
15
6
2022
entrez:
25
3
2022
Statut:
ppublish
Résumé
The current scenario of typhoid fever warrants early prevention with typhoid conjugate vaccines in susceptible populations to provide lifelong protection. We conducted a multicenter, single-blind, randomized, Phase 2/3 study to assess the immunogenicity and safety of Biological E's Typhoid Vi-CRM
Identifiants
pubmed: 35333702
doi: 10.1080/21645515.2022.2043103
pmc: PMC9196756
doi:
Substances chimiques
Typhoid-Paratyphoid Vaccines
0
Vaccines, Conjugate
0
Types de publication
Clinical Trial, Phase II
Clinical Trial, Phase III
Journal Article
Multicenter Study
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2043103Références
Trop Med Int Health. 2016 Oct;21(10):1255-1262
pubmed: 27495900
Indian J Med Res. 2020 Jan;151(1):22-34
pubmed: 32134011
Lancet Infect Dis. 2014 Feb;14(2):119-29
pubmed: 24290843
Clin Infect Dis. 2020 Jul 29;71(Suppl 2):S141-S150
pubmed: 32725225
Indian J Med Res. 2019 Nov;150(5):437-447
pubmed: 31939387
Bull World Health Organ. 2008 Apr;86(4):260-8
pubmed: 18438514
Cochrane Database Syst Rev. 2018 May 31;5:CD001261
pubmed: 29851031
Lancet. 2015 Mar 21;385(9973):1136-45
pubmed: 25458731
Hum Vaccin. 2011 Aug;7(8):883-5
pubmed: 21791973
Vaccine. 1999 Oct 1;17 Suppl 2:S22-7
pubmed: 10506405
Expert Rev Vaccines. 2013 Nov;12(11):1273-86
pubmed: 24156285
Lancet Infect Dis. 2019 Jan;19(1):e26-e30
pubmed: 30170987
Vaccine. 2012 Sep 21;30(43):6111-4
pubmed: 22705173
J Clin Diagn Res. 2015 May;9(5):SC01-3
pubmed: 26155525
Acta Medica (Hradec Kralove). 2018;61(4):125-130
pubmed: 30664444
Lancet Glob Health. 2017 Mar;5(3):e310-e323
pubmed: 28193398
Lancet. 1999 Aug 28;354(9180):734-7
pubmed: 10475185
PLoS One. 2011;6(9):e25398
pubmed: 21980445
Emerg Infect Dis. 2005 Feb;11(2):326-9
pubmed: 15752457
Vaccine. 2021 May 6;39(19):2620-2627
pubmed: 33849723
Lancet Infect Dis. 2019 Apr;19(4):369-381
pubmed: 30792131
BMC Public Health. 2018 May 3;18(1):594
pubmed: 29724223
Vaccine. 2019 Jan 7;37(2):214-216
pubmed: 29661581
Vaccines (Basel). 2018 Jul 24;6(3):
pubmed: 30042307
N Engl J Med. 2009 Jul 23;361(4):335-44
pubmed: 19625715
Vaccine. 2011 Jan 17;29(4):712-20
pubmed: 21115057
J Glob Health. 2015 Dec;5(2):020407
pubmed: 26649174
Indian Pediatr. 2021 Jan 15;58(1):44-53
pubmed: 33257602